Table 1. Approximate treatment success per protocol with susceptible strains (Western results)1.
Therapy | Days | Success |
---|---|---|
Clarithromycin triple therapy | 7 | 94% |
Clarithromycin triple therapy | 14 | 97% |
Sequential therapy | 10 | 94% |
Sequential therapy | 14 | 97% |
Hybrid therapy | 14 | 97% |
Fluoroquinolone triple | 7 | <80% |
Fluoroquinolone triple | 10 | <90% |
Fluoroquinolone triple | 14 | 96% |
PPI + amoxicillin1 | 5 | 10% |
PPI + amoxicillin1 | 7 | 15% |
PPI + amoxicillin | 10 | 20% |
PPI + amoxicillin1 | 14 | 50% |
PPI metronidazole triple | 7 | 94% |
PPI metronidazole triple | 14 | 97% |
PPI- bismuth tetracycline, metronidazole | 14 | >95% |
=Equals triple therapies but with clari, met, or fluoroquinolone resistance infections